Scrap Citizen Petition Proposal For 505(b)(2), Off-Patent Industry Urges FDA
Citizen Petitions Can ‘Languish Unanswered’ For Years
Several stakeholders across the off-patent industry, including trade groups and manufacturers, have encouraged the FDA to scrap its proposal to require companies to submit citizen petitions for requesting therapeutic equivalence evaluations for 505(b)(2) applications.
